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ABSTRACT
CPEB3 is a sequence-specific RNA-binding protein
and represses translation of its target mRNAs
in neurons. Here, we have identified a novel
function of CPEB3 as to interact with Stat5b and
inhibit its transcription activity in the nucleus
without disrupting dimerization, DNA binding and
nuclear localization of Stat5b. Moreover, CPEB3 is
a nucleocytoplasm-shuttling protein with predomin-
ant residence in the cytoplasm; whereas activation
of NMDA receptors accumulates CPEB3 in the
nucleus. Using the knockdown approach, we have
found the receptor tyrosine kinase, EGFR, is a target
gene transcriptionally activated by Stat5b and
downregulated by CPEB3 in neurons. The increased
EGFR expression in CPEB3 knockdown neurons,
when stimulated with EGF, alters the kinetics of
downstream signaling. Taken together, CPEB3
has a novel function in the nucleus as to suppress
Stat5b-dependent EGFR gene transcription.
Consequently, EGFR signaling is negatively
regulated by CPEB3 in neurons.
INTRODUCTION
Long-term memory requires synthesis of plasticity-related
proteins (PRPs) to strengthen synaptic efﬁcacy and con-
sequently consolidate memory. RNA-binding proteins
play indispensable roles to control spatial-temporal PRP
production by regulating transport, localization, transla-
tion and/or degradation of PRP RNAs (1–4). Cytoplasmic
polyadenylation element binding protein (CPEB)-like
proteins, CPEB2, CPEB3 and CPEB4, in vertebrates
likely inﬂuence PRP synthesis for the following reasons.
CPEB3 and CPEB4 are expressed predominantly in
neurons and CPEB3-repressed translation of a reporter
RNA is abrogated by the activation of N-methyl-D-
aspartic acid receptor (NMDAR) (5). CPEB3 and
CPEB4 mRNAs are elevated in the hippocampus after
kainate-induced seizure, indicating they are immediate
early gene products upon synaptic activation and likely
modulate neuronal function (6). Importantly, Orb2 in
Drosophila is required for long-term conditioning of
male courtship behavior (7), implicating that its mamma-
lian homologs, CPEBs2–4, may also have roles in
memory. A recent study has shown that a single nucleotide
polymorphism in the CPEB3 gene is associated with
human episodic memory (8).
CPEBs2–4 were ﬁrst identiﬁed based on sequence simi-
larity with CPEB (or CPEB1) in the carboxyl terminal
RNA-binding domain (9). However, CPEBs2–4 could
interact with RNA sequences identiﬁed from a SELEX
(systematic evolution of ligands by exponential enrich-
ment) screen that are different from the conventional
CPEB1-binding site (UUUUA1-2U) (5). Despite
CPEB1-controlled translation is characterized at the mo-
lecular details and plays important roles in development,
cell cycle, neuronal plasticity and cellular senesce (10),
much less is known about the functional entities of
CPEBs2–4 once they bind to RNAs. A previous study
has shown that CPEB3 repressed translation of a
reporter RNA and Glu2 RNA (5). Interestingly, a
prion-like property has been observed in Orb2 as well as
Aplysia CPEB in yeasts (11) and a recent study has shown
that multimeric state of CPEB is required for maintaining
long-term facilitation in Aplysia (12). Nonetheless,
whether any mammalian CPEB possesses prion-like
change to modulate its target RNA translation is still in
question. To understand how CPEB3 regulates transla-
tion, we used a yeast two-hybrid screen to identify its
binding partners. Unexpectedly, the screen identiﬁed a
transcription factor, signal transducer activated transcrip-
tion (Stat) 5b, interacted with CPEB3. Stat5b is one of the
seven Stat family members of which transcriptional
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that are activated by cytokines and hormones (13,14).
Translocation of dimerized Stat to the nucleus activates
target gene transcription (15). Using promoter assays,
CPEB3 inhibits Stat5b-dependent transcription without
affecting DNA binding, nuclear translocation and dimer-
ization of Stat5b. Moreover, CPEB3 shuttles between the
nucleus and cytoplasm and activation of NMDARs in-
creases nuclear level of CPEB3, suggesting that neuronal
activity regulates CPEB30s roles in transcription and
translation.
One target gene transcriptionally regulated by Stat5b
and CPEB3 interaction identiﬁed from this study is the
receptor tyrosine kinase, epidermal growth factor
receptor (EGFR). Upon ligand binding, the receptors
become phosphorylated on tyrosine residues within their
cytoplasmic kinase domain and activated which then
initiate several downstream signaling pathways, such as
JAK-Stat, mitogen-associated protein kinase (MAPK)
and phosphatidylinositol 3-kinase (PI3K)-Akt. The
elevated EGFR level in CPEB3 knockdown neurons,
when stimulated with EGF, results in extended and
ampliﬁed downstream signaling measured by phosphoryl-
ation of Stat5b and Akt. Although EGFR has been
studied extensively in cell proliferation (including neuro-
genesis), anti-apoptosis and cancer progression (16–18), its
function in post-mitotic neurons is less characterized. In
the EGFR null mice, abnormal astrocyte development
and neuronal death impede the study of EGFR function
in the adult brain (19,20), but it has been demonstrated
that EGF enhances long-term potentiation in the
hippocampal slices and dentate gyrus of anesthetized
rats after tetanic stimulation (21,22), suggesting its corres-
ponding receptor, EGFR, may function as a neuronal
modulator. Using pharmacological approach, activation
or deprivation of EGFR’s kinase activity by infusing
EGF or geﬁtinib (23), respectively, in the brain, affects
spatial learning and memory performance in mice.
Together, this study ﬁrst identiﬁes a novel transcriptional
function for the CPEB family members besides their
characterized roles in translation (5,10,24,25). By interact-
ing with Stat5b, CPEB3 downregulates the expression of
EGFR of which kinase activity modulates learning and
memory.
MATERIALS AND METHODS
Antibodies
Antibodies used for the study are, Akt (cat #4691),
pT308-Akt (cat #2965), pY1068-EGFR (cat #2236S) and
pY699-Stat5 (cat #9359) from Cell Signaling; EGFR (cat
#SC-03) and Stat5b (cat #SC1656) from Santa Cruz
Biotechnology; synaptophysin (cat #MAB5258) and
MAP2 (cat #MAB378) from Chemicon and ﬂag epitope
(cat #F1804) from Sigma-Aldrich.
Yeast two-hybrid screen
Matchmaker Two-Hybrid Library Construction and
Screening Kit (Clontech) was used to construct a
random-primed adult mouse brain cDNA library.
Brieﬂy, mouse brain poly(A) RNA (Ambion) and the
CDS III/6 primer were used to generate double-stranded
cDNA that was co-transformed with linearized
pGAD-Rec vector into the yeast strain, AH109.
Approximately 5.5 10
5 transformants were harvested,
mixed and stored at  80 C. The N-terminus of hCPEB3
(amino acids 1–427) was cloned into pGBKT7 and trans-
formed into the yeast strain, Y187 (screening bait). Both
yeast strains were mated for 24h at 30 C with gentle
swirling at 40rpm then plated in nutrient-selective plates
(SD/X-a-gal/-Leu/-Trp/-Ade/-His) to screen for positive
interaction clones.
Plasmid construction
The shRNA sequences, ACAAACCTGTTCAAATCC
and CAATACTGGGAATAAATC targeted against rat
CPEB2 and CPEB4 mRNAs respectively, were cloned
into lentiviral vector pLL3.7-Syn (26). The shRNA
clone, TRCN0000012554 against rat Stat5b (CGGCCA
AAGGATGAAGTATAT), was obtained from the
RNAi Core Facility (Academia Sinica). The various
truncated Stat5b mutants were PCR ampliﬁed and
cloned into pGADT7 for two-hybrid interaction.
Cell culture and lentivirus infection
HEK-293T and COS7 cells were cultured in DMEM with
10% FBS. Cultures of rat hippocampal neurons (27) were
grown at a cell density of 8000/cm
2 on coverslips
or 30000/cm
2 on dishes. Hippocampal neurons of DIV
6 were infected with lentivirus overnight and harvested
on DIV 11 for RNA or protein extraction. On the
day of harvest, the concentrations of reagents used to
treat neurons are: 50mM NMDA, 15mM AMPA, 50mM
DHPG, 30mM KCl, 30mM APV, 20mM NBQX, 5ng/ml
leptomycin B, 100ng/ml EGF, 30mg/ml cycloheximide
and 2mg/ml actinomycin D.
Co-immunoprecipitation (Co-IP)
For co-IP, 4mg of DNA mixtures containing equal
amounts of two or three plasmids were co-transfected
in a 6-cm dish of 293T cells using lipofectamine 2000.
The overnight transfected cells were lysed in 120ml
IP buffer (20mM Hepes, pH 7.4, 100mM NaCl, 1mM
MgCl2, 0.1% NP40, 10% glycerol, 0.5mM DTT,
1  protease inhibitor cocktail and 100mg/ml RNaseA)
and centrifuged at 10000 g for 5min at 4 C. The super-
natant was incubated with protein G beads bound
with myc or ﬂag antibody (Ab) for 2h at 4 C. The
beads were washed ﬁve times with 300ml IP buffer
and the precipitated proteins were used for western
blotting. For reciprocal IP of endogenous CPEB3
and Stat5b,  4 10
7 cortical neurons were lysed in
1.6ml IP buffer. Equal volumes of lysate were incubated
with Stat5b, CPEB3 or control IgG and the immuno-
precipitates were probed with CPEB3 and Stat5b
antibodies.
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PCR (Q–PCR)
Total RNA was extracted with Trizol (Invitrogen). The
cDNA was synthesized using oligo-dT primer
and ImPromII Reverse Transcriptase (Promega).
Quantitative PCR was conducted using the Universal
Probe Library and Lightcycler 480 system (Roche). Data
analysis was done using the comparative Ct (threshold
cycle value) method with the non CPEB3-targeted RNA,
NF-M mRNA as the reference. The PCR primers are:
EGFR, 50-TGCACCATCGACGTCTACAT-30 and 50-A
ACTTTGGGCGGCTATCAG-30; CPEB3, 50-TGGAGA
ACTCCTTAATGGATATGA-30 and 50-AAGTTTATTC
CCATGCGTCCT-30; Stat5b, 50-GGAGAGCCTACGGA
TCCAA-30 and 50-AGGGACACTTGCTTCTGCTG-30;
NF-M, 50-CGTCATTTGCGAGAATACCA-30 and 50-T
CTTCACCCTCCAGTAGTTTCC-30.
Chromatin immunoprecipitation (ChIP)
Approximately 3 10
7 cortical neurons of DIV11 were
crosslinked with 1.42% formaldehyde for 15min and
quenched with 125mM glycine for 5min at room tempera-
ture. The ﬁxed cells were washed three times with ice-cold
PBS, lysed in 3ml of ChIP buffer (50mM Tris, pH 7.5,
150mM NaCl, 5mM EDTA, 0.5% NP40 and 1% Triton)
and sonicated for 10min with 30s on/off cycles. The
sonicated sample was centrifuged for 5min at 12000 g
at 4 C and equal volumes of supernatant were incubated
overnight with the protein G beads with Stat5b or mouse
IgG. The beads were washed three times with ChIP buffer
containing 500mM NaCl followed by another three
washes with ChIP buffer. One-third of beads were eluted
with Laemmli sample buffer for western blot analysis and
the remaining beads along with the saved input sample
were incubated at 95 C for 15min and digested with
Proteinase K (1mg/ml in 50mM Tris, pH 7.4, 10mM
EDTA, 50mM NaCl and 1% Triton X-100) at 55 C for
30min. The supernatants were phenol/chloroform ex-
tracted, ethanol precipitated in the presence of 10mg
yeast tRNA as a carrier and used for PCR analysis.
Primers used to detect binding to the  3000 to +300
promoter region and a negative control spanning intron
24 and exon 25 of the EGFR gene are:  2790 to  2581:
50-CGACTGACCTCTGAATGTCC-30 and 50-TGCTTG
GTTGGTAGTCCAGT-30;  2299 to  1981: 50-GACCT
AAGTTCTTATTCGGAAC-30 and 50-TACCACATGGT
AGCCTGGCA-30;  2001 to  1641: 50-ATGCCAGGCT
ACCATGTGGTA-30 and 50-AAGCTGTGGAAATGTA
GAGCA-30;  1475 to  1061: 50-CCACTTTATATAAA
ACCCCTG-30 and 50-AAGACCAACTAATGTCAC
TGC-30;  510 to  101: 50-GGTAGGACAGTAACCGA
GG-30 and 50-CTAGCTAGCCCTGGTCGG-30; Intron24
and exon25: 50-TGGCAGACCTTGTAGACAGT-30 and
50-CGTCTTCCATGTCCTCCTC-30.
Luciferase reporter assay
A mixture of  0.5mg of plasmid DNA containing 0.2mg
Stat5b, 0.2mg CPEB3, 0.1mg ﬁreﬂy luciferase reporter and
5ng Renilla luciferase were simultaneously transfected
into 293T cells with Fugene HD (Roche). Cells were har-
vested 20–24h after transfection and analyzed using
Dual-Luciferase Reporter Assay System (Promega).
Animal surgery and Morris water maze
All experimental protocols were carried out following
guidelines of the Institutional Animal Care & Utilization
Committee. For intracerebroventricular drug administra-
tion, the 8-week-old male C57BL/6J mouse was
anesthetized with ketamine before implanting a cannula
at the right lateral ventricle (1.0mm lateral and 0.5mm
caudal to bregma to a depth of 3.0mm from the skull)
that was attached to an Alzet osmotic Y pump (Model
1004) to infuse drug at 0.11ml/h for 14 days.
Recombinant EGF (Sigma-Aldrich) and geﬁtinib (ﬁrst
constituted to 5mM in DMSO, Astra Zeneca) were
diluted at the concentration of 50mg/ml and 50mM, re-
spectively, in the vehicle (artiﬁcial cerebrospinal ﬂuid con-
taining 1mg/ml BSA). One week after the surgery, mice
with complete wound-healing were subject to Morris
water maze task (28). Training for the hidden platform
version consisted of four trials each day for four consecu-
tive days. The probe trial was administered on the day
after training completed. The visible platform task,
which consisted of four trials for 1day with the escape
platform marked by a visible ﬂag, was conducted to
ensure the intact vision of mice. For all the trials, the
maximal swimming duration was 60s and the inter-trial
interval was 60min. The trajectories of mice were recorded
and analyzed with a video tracking system, TrackMot
(Singa Technology, Taiwan). Data were represented with
mean±S.E.M. and one-way and two-way ANOVA and
post hoc LSD tests were used for statistics.
RESULTS
CPEB3 interacts with Stat5b and inhibits
Stat5b-dependent transcription
A yeast two-hybrid screen was performed using the
N-terminal 427 amino acids of human CPEB3 as the
bait to probe a mouse brain cDNA library. Two positive
clones contained the C-terminal regions of Stat5b were
identiﬁed (Figure 1A). Further analysis showed that the
amino acids 639–700 between Src-homology (SH2) and
transactivation domain (TAD) of Stat5b were crucial for
its association with the N-terminus of CPEB3 (Figure 1A).
In this region, tyrosine 699 (Y699) is phosphorylated upon
cytokine and growth hormone stimulation that enhances
Stat5b’s transactivation ability (13,14). When myc-tagged
full length (myc-CPEB3) and C-terminal RNA-binding
domain (myc-CPEB3C) of CPEB3 along with ﬂag-tagged
Stat5b were expressed in 293T cells, myc-CPEB3 but not
myc-CPEB3C was co-precipitated with ﬂag-Stat5b in the
presence of RNase A treatment, indicating this interaction
is mediated through the CPEB3N-terminus in an
RNA-independent manner (Figure 1B). Furthermore,
using cortical neuronal lysate to perform reciprocal
immunoprecipitation, endogenous CPEB3 was pulled
down in the Stat5b immunoprecipitate and vice versa
(Figure 1C).
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critical residue Y699, we questioned whether CPEB3
could interfere with Stat5b-mediated transcription and
whether Y699 phosphorylation affects Stat5b and
CPEB3 interaction. To monitor Stat5b-dependent tran-
scription, we used the IGF1 promoter containing two
Stat5b-binding sites or as a control, the both sites were
mutated (mut) (29). The nuclear localization sequence
(NLS) of SV40 large T antigen, PKKKRKVG, was
appended to the C-terminus of CPEB3 to facilitate its
nuclear localization since CPEB family proteins are pre-
dominantly cytoplasmic (Figure 2B, immunostained
pictures). The wild-type (WT) and constitutively active
(CA) forms of Stat5b, carrying the N642H mutation
that hindered dephosphorylation of Y699 (30), were
employed for the assay. The Renilla luciferase plasmid
was included to normalize variation in transfection
efﬁciencies. The ratio of normalized luciferase activity
(i.e. ﬁreﬂy/Renilla) obtained in the presence of CA
versus WT Stat5b was considered as fold of transcription-
al activation caused by phosphorylated Y699 (p-Y699)
(Figure 2A). This approach mimics cytokine-induced
Stat5b phosphorylation-activated transcription while
avoids simultaneously activating other signaling molecules
to compromise the promoter assay (31). In the presence of
enhanced green ﬂuorescent protein (EGFP, a control), a
3-fold transactivation was observed in the wild-type but
not the mutant promoter. Such activation was decreased
to 2.2-fold with myc-CPEB3 and further reduced to
1.5-fold with nucleus-localized form of CPEB3
(myc-CPEB3NLS). In contrast, myc-CPEB3C, which
was predominantly nuclear, did not affect
Stat5b-induced transcription since it did not bind Stat5b
(Figure 1B). Because Stat5bWT and Stat5bCA interact
similarly with myc-CPEB3 (Figure 2C), the N642H re-
placement and Y699 phosphorylation have no effect on
Stat5b’s association with CPEB3.
CPEB3 suppresses Stat5b’s transcription activity without
affecting dimerization and DNA binding of Stat5b
To examine whether CPEB3 could disrupt dimerization of
Stat5b and hence inhibit Stat5b’s activity, ﬂag-Stat5b
and red ﬂuorescence protein cherry (chRFP)-fused
Stat5b along with myc-CPEB3 or EGFP were
co-expressed in 293T cells. Figure 3A shows the amount
of chRFP-Stat5b dimerized with ﬂag-Stat5b is not
inﬂuenced by myc-CPEB3. Moreover, growth
factor-induced Y699 phosphorylation does not change
Stat5b’s self-dimerization and association with CPEB3
(Figure 3B). Because p-Y699 is evidently detected in
Stat5bCA (Figure 2B), Stat5b is constantly
phosphorylated and dephosphorylated in 293T cells even
without growth factor stimulation. To test whether
CPEB3 could inhibit the transcription mediated by
non-phosphorylated Stat5b, the Y699F mutant was
used. The nuclear form of CPEB3 further diminished
Stat5b-mediated transcription regardless of the phosphor-
ylation status of Y699 (Supplementary Figure S1). To
conﬁrm that CPEB3-mediated suppression does not
require interference with Stat5b’s DNA binding, Stat5b
and a control, FoxP2, were fused to Gal4 DNA-binding
domain (Gal4DBD) that bound to the Gal4-binding
promoter sequences. In the presence of myc-CPEB3,
myc-CPEB3NLS or myc-CPEB3C expression, the trans-
activation ability of Gal4DBD-Stat5b but not that of the
controls was perceptibly inhibited by nucleus-localized
CPEB3 (Figure 3C). Because CPEB3-NLS represses
Stat5b’s activity greater than CPEB3, it is unlikely such
inhibition is caused by sequestering Stat5b in the cyto-
plasm. Thus, CPEB3 suppresses Stat5b-dependent tran-
scription without disrupting DNA binding, dimerization
and nuclear localization of Stat5b and such a negative
regulation is not dependent on Y699 phosphorylation of
Stat5b.
Activation of NMDARs inﬂuences nucleocytoplasmic
distribution of CPEB3
Because CPEB3-repressed Stat5b-dependent transcription
was manifest even when CPEB3 was not appended with
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Figure 1. CPEB3 interacts with Stat5b. (A) Salient features of Stat5b
showing the N-terminal region, coiled-coil domain, DNA-binding
domain (DBD), Src-homology (SH2) and transactivation domain
(TAD). The transcriptional activity of Stat5b is enhanced when the
denoted tyrosine 699 (Y699) is phosphorylated upon growth hormone
stimulation. When asparagine 642 mutated to histidine (N642H), it
improves Stat5b’s activity by hindering dephosphorylation of
phosphorylated Y699. Using the N-terminus (amino acids 1–427) of
CPEB3 as the bait, a yeast two hybrid (Y2H) screen identiﬁed two
clones corresponding to the amino acids 589–743 and 611–786 of
Stat5b. The wild-type and truncated Stat5b mutants were tested for
positive (+) or negative (–) interaction with the N-terminus of
CPEB3. (B) Co-immunoprecipitation (Co-IP) assay. The plasmid ex-
pressing ﬂag-Stat5b or a control EGFP along with plasmids encoding
myc-tagged full-length (myc-CPEB3) and the C-terminal RNA-binding
domain of CPEB3 (myc-CPEB3C) were cotransfected into 293T cells.
The cell lysates were precipitated with ﬂag antibody (Ab) and
immunoblotted with myc Ab. IB: immunoblotting, IP: immunopre-
cipitation. (C) Reciprocal immunoprecipitation assay. The lysate from
cortical neurons was precipitated with control, Stat5b or CPEB3 Ab
and immunoblotted with CPEB3 and Stat5b Abs.
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nucleocytoplasmic shuttling protein with longer residency
in the cytoplasm, and whether neuronal activity could
modulate CPEB3 distribution. Hippocampal neurons
of day in vitro (DIV) 12 were stimulated with various
glutamate receptor agonists, a-amino-3-hydroxyl-5-
methyl-4-isoxazole-propionate (AMPA), NMDA and
3,5-dihydroxyphenylglycine (DHPG), for 30min and
immunostained with afﬁnity-puriﬁed CPEB3 antibody.
Five hundred neurons were scored with the staining
signal greater in the cytoplasm than in the nucleus
categorized as cytoplasm-localized; while the rest
was considered as nucleus-localized. The majority of un-
stimulated neurons showed a stronger CPEB3 signal in the
cytoplasm with <10% of cells displaying nuclear distribu-
tion. AMPA and NMDA induced >60% of cells exhibited
stronger or similar CPEB3 signals in the nucleus
(examples in Figure 4A and quantiﬁed results in Figure
4B). To conﬁrm the above observation was not caused
by antibody’s cross-reactivity or changes in nuclear
permeability,neuronsexpressingmyc-CPEB3andacontrol
ﬂag-FKBP8 were stimulated. Both AMPA and NMDA
stimulations shifted the distribution of myc-CPEB3 but
not ﬂag-FKBP8 from cytoplasmic to nuclear dominance
(Supplementary Figure S2A). KCl depolarization which
triggered presynaptic release of glutamate and subse-
quently activated postsynaptic glutamate receptors, also
resulted in nuclear CPEB3 accumulation in a NMDAR-
dependent manner since the addition of NMDAR
blocker, (2R)-amino-5-phosphonovaleric acid (APV), but
not the AMPAR antagonist, 2,3-dihydroxy-6-nitro-7-
sulfamoyl-benzoquinoxaline-2, 3-dione (NBQX), was suf-
ﬁcient to prevent this event (Figure 4B). Interestingly, the
AMPA effect on CPEB3 distribution was mediated
through NMDAR signaling because it was blocked not
only by NBQX but also by APV. Therefore, it appears
that AMPAR activation, similar to KCl treatment,
results in depolarization of neurons that potentiates
synaptic release of glutamate and expels Mg
2+ clogs
from NMDARs, hence facilitates NMDAR activation.
A translation inhibitor, cycloheximide (CHX), did not
affect KCl-induced CPEB3 redistribution, so the nuclear
accumulated CPEB3 is not newly synthesized (Figure 4B).
Despite the NLS and nuclear export sequence (NES) in
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Figure 2. CPEB3 inhibits Stat5b-dependent transcription. (A) The 293T cells were transfected with plasmids encoding (i) EGFP, myc-CPEB3,
myc-CPEB3 fused with the nuclear localization sequence (myc-CPEB3NLS) or myc-CPEB3C, and (ii) wild-type (WT) or constitutively active
(CA) Stat5b with N642H mutation, and (iii) reporters expressing ﬁreﬂy luciferase driven by the IGF1 promoter containing two wild-type or
mutated Stat5b-binding sites along with Renilla luciferase. TK: thymidine kinase promoter. Stat5b-mediated transactivation is expressed as fold
of induction of normalized luciferase activity (ﬁreﬂy/Renilla) obtained in the presence of CA verse WT Stat5b. Three independent experiments were
analyzed and expressed as mean±s.e.m. and the asterisks denote signiﬁcant difference (Student’s t-test). (B) Subcellular distribution of myc-CPEB3,
myc-CPEB3NLS and myc-CPEB3C in 293T cells. (C) CPEB3 interacts similarly with Stat5b and Stat5bCA. The extracts containing myc-CPEB3 and
WT or CA ﬂag-Stat5b, were precipitated with myc Ab and probed with ﬂag, p-Stat5b and myc Abs.
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mediated by chromosome region maintenance 1 (CRM1)
since blocking CRM1 by leptomycin B (LMB) induced
nuclear accumulation of CPEB3. Moreover, application
of LMB in COS cells expressing GFP-tagged CPEB3
also caused GFP-CPEB3 retained in the nucleus
(Figure 4C), suggesting CPEB3 constantly shuttles
between nucleo-cytoplasmic compartments and activation
of NMDARs modulates its distribution equilibrium. In
contrast, Stat5b was present in both nucleus and
cytoplasm and the stimulation with AMPA, NMDA and
DHPG did not change its distribution (data not shown).
Although NMDAR signaling increased nuclear CPEB3, it
did not affect Stat5b distribution (see immunostaining in
Supplementary Figure S2B and biochemical fractionation
in Supplementary Figure S3), indicating the two factors
were unlikely co-transported in response to neuronal
activity. Moreover, the co-immunoprecipitation assay
demonstrated that CPEB3 and Stat5b remained
associated in both cytoplasmic and nuclear extracts
isolated from neurons treated with NMDA
(Supplementary Figure S3).
Stat5b-activated EGFR transcription is downregulated
by CPEB3
To identify a target gene regulated by Stat5b and CPEB3
interaction, we focused on EGFR because hepatic EGFR
RNA was reduced in Stat5b knockout mice in the
pervious microarray study (32) and the isotope-coded
afﬁnity tag (ICAT) proteomic analysis displayed a
two-fold increase of EGFR protein in CPEB3 knockdown
(KD) neurons (unpublished data). Hippocampal neurons
of DIV6 were infected overnight with lentivirus containing
or lacking a short hairpin sequence for rat CPEB3 or
Stat5b. The infected neurons were harvested on DIV11
for RNA and protein analysis. The RNA levels of
EGFR, CPEB3 and Stat5b were measured by quantitative
PCR following reverse transcription (RT–QPCR). If
EGFR transcription is activated by Stat5b whose transac-
tivation ability is offset by CPEB3, a decrease and an
increase in EGFR RNA level is expected, respectively, in
Stat5bKD and CPEB3KD neurons as seen in Figure 5A.
These changes are results of transcription since EGFR
RNA stability is similar in the control and knockdown
neurons (Figure 5B, normalized curves). To ascertain
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Nucleic Acids Research, 2010,Vol.38, No. 21 7451that Stat5b binds to the EGFR promoter, we performed
chromatin immunoprecipitation (ChIP). Stat5b-binding
sites in the proximal 3kb EGFR promoter
(Supplementary Figure S4) were predicted by MATCH
analysis (33). Formaldehyde-ﬁxed cortical neurons were
lysed and precipitated with Stat5b antibody. In
Figure 5C, an extra immunostained band of higher mo-
lecular weight likely represents crosslinked dimeric Stat5b
as it was not observed when using unﬁxed neurons
(Figure 1C). The promoter regions spanning the predicted
Stat5b-binding sites at  2694,  2234,  2035 and  1804
were preferentially PCR-ampliﬁed from the Stat5b IgG-
precipitated substance. In contrast, the areas around
 1437,  1250,  1102,  470,  467,  181 as well as a
control region spanning intron 24 and exon 25 of EGFR
gene were not. The same Stat5b-binding regions in the
EGFR promoter were also identiﬁed in another ChIP
assay (Supplementary Figure S5). Finally, the EGFR
protein level was examined using CPEB2, CPEB3,
CPEB4 and Stat5b knockdown neurons. As expected, a
reduction in CPEB3 leads to an increase in EGFR synthe-
sis whereas a deﬁciency in Stat5b results in a decrease in
EGFR expression (Figure 5D). The elevated EGFR ex-
pression in CPEB3 KD neurons could be rescued with the
expression of full length human CPEB3 (hCPEB3), to a
lesser extent with the N-terminus but not the C-terminus
of hCPEB3 (Supplementary Figure S6). Intriguingly, the
knockdowns of CPEB2 and CPEB4 have no obvious
effect on EGFR expression (5). Since the nuclear history
of mRNA could inﬂuence its expression pattern later in
the cytoplasm (34), we determined if CPEB2 and CPEB4
did not regulate EGFR synthesis because of lacking inter-
action with Stat5b. In 293T cells that expressing
ﬂag-Stat5b along with various myc-tagged CPEBs, only
myc-CPEB3 was co-immunoprecipitated with ﬂag-Stat5b
(Figure 5E). The inability of CPEB2 and CPEB4 to bind
Statb5b is not due to their failure to translocate to the
nucleus, as when CRM1-mediated export was blocked,
GFP-CPEB2 and GFP-CPEB4 were accumulated in the
nucleus (Supplementary Figure S7).
The kinetics of EGFR downstream signaling is altered in
CPEB3 knockdown neurons
In cultured hippocampal neurons, the kinase activity of
EGFR as assessed by autophosphorylation of Y1068 is
relatively inert. Stimulating neurons with DHPG (data
not shown), AMPA and NMDA apparently did not
release, if any, sufﬁcient amount of endogenous EGFR
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7452 Nucleic Acids Research, 2010,Vol.38, No. 21ligands to yield detectable p-Y1068 (Figure 6A). To
address whether aberrant EGFR expression in
CPEB3KD neurons changed downstream signaling, the
neurons were stimulated with EGF and monitored for
the activation of EGFR (p-Y1068), Stat5b (p-Y699) and
Akt (p-T308) (Figure 6B). The increased p-Y1068 signal in
KD neurons was caused by elevated EGFR expression;
once normalized; the kinetics of EGFR activation
(p-Y1068) was similar in control and KD neurons
(Figure 6B, top plot). Since ligand-activated EGFR was
endocytosed and degraded in proteasome and
lysosome-dependent manner (35,36), a decline of EGFR
level was observed in EGF-treated samples. In addition,
EGF-stimulated CPEB3KD neurons displayed prolonged
and augmented activation of Stat5b (p-Y699) and Akt
(p-T308), respectively (Figure 6B, bottom plots). As a
control, Akt activation showed similar kinetics in
NMDA-stimulated control and CPEB3KD neurons, sug-
gesting CPEB3KD effect on Akt signaling is distinctively
tailored to speciﬁc stimulus like EGF (Figure 6C). In
addition, the Y699 phosphorylation of Stat5b is not de-
tectable upon NMDA stimulation, indicating NMDAR
signaling does not affect Stat5b transcriptional activity
via Y699 phosphorylation.
EGFR is involved in modulating learning and memory
Because activation of EGFR initiates several signaling
pathways, such as PI3K-Akt and MAPK, in parallel
that have been implicated in plasticity and memory, per-
turbation of this receptor tyrosine kinase activity locally in
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Nucleic Acids Research, 2010,Vol.38, No. 21 7453the brain may inﬂuence memory performance. To assess
whether EGFR is a PRP that functions in learning and
memory, pharmacological treatment of mice with EGF
ligand and the inhibitor geﬁtinib was used. EGF-induced
EGFR activation in the cultured neurons was effectively
suppressed by geﬁtinib (Figure 7A). Male C57/BL6J mice
with indwelling cannulae in the lateral ventricle infused
with vehicle, EGF or geﬁtinib were tested for spatial
learning and memory using Morris water maze. The
mice received four spatial trials per day with a 60min
inter-trial interval and learned to locate a hidden
platform using extra maze visual cues during 4-day
spatial acquisition trials. No difference in swimming
speed of all drug-treated animals was observed
(Figure 7B). Animals infused with EGF trended towards
enhanced performance in terms of accuracy and latency
of locating the platform (Figure 7C). Such a mild change
could be due to the reduced surface level of EGFR
since persistent activation by EGF resulted in continuous
endocytosis and degradation of the receptors (35,36).
During the probe trial, the hidden platform was
removed and the amount of time and distance mice
spent in the original platform quadrant was recorded to
test their consolidated memory after 4-day trials
(Figure 7D). Deprivation of EGFR activity with geﬁtinib
clearly retarded learning and memory performance as
demonstrated in decreased accuracy and increased
latency in each trial (Figure 7C) as well as reduced reten-
tion in the target quadrant in the probe trial (Figure 7D).
DISCUSSION
We have identiﬁed a novel role for the RNA-binding
protein, CPEB3 in transcription. All CPEBs, originally
thought to be localized in the cytoplasm, are now
proteins shuttling between nucleocytoplasmic compart-
ments. Two recent studies have shown that CPEB1
shuttles to the nucleus where it possibly plays a role in
ribosomal biogenesis (37) and alternative splicing (38).
One nuclear function of CPEB3 is to downregulate
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7454 Nucleic Acids Research, 2010,Vol.38, No. 21Stat5b’s transcriptional activity; whereas the roles of
nuclear CPEB2 and CPEB4 remain to be determined.
Interestingly, NMDAR signaling reorganizes CPEB3 dis-
tribution from cytoplasmic to nuclear prevalence, suggest-
ing neuronal activity could regulate and partition
CPEB30s functions between the two compartments to
control gene expression. One target gene transcriptionally
regulated by CPEB3 is EGFR of which function in
modulating learning and memory has been pharmaco-
logically demonstrated in the present study.
The classical cytokine-Stat-signaling draws a paradigm
in which cytokine-induced phosphorylation on a critical
tyrosine residue of cytoplasmic Stats is the prerequisite to
initiate dimerization and subsequent nuclear translocation
of Stats. Thus, this phosphorylation is essential to trans-
duce the extracellular signal to the nucleus and to activate
Stat-dependent gene transcription (15,39). However, the
ﬁnding that non-phosphorylated Stat1 (Y701F mutant)
could bind to and activate the low molecular weight
polypeptide-2 promoter (40) and accumulating evidences
have subsequently demonstrated this phosphorylation
event is not necessarily required for Stat’s dimer forma-
tion, constitutive transit in and out of nucleus and tran-
scriptional activation (41) that are in accordance with our
ﬁndings in this study. Silencing mediator for retinoic acid
receptor and thyroid hormone receptor (SMRT), which
binds to the N-terminal coiled-coil domain of STAT5
and suppresses the induction of STAT5 target genes (42)
is the only identiﬁed transcriptional co-repressor of Stat5.
Here, we have uncovered CPEB3 as another negative
regulator for Stat5b without affecting Stat5b’s dimeriza-
tion, nuclear localization and DNA binding. The activa-
tion domains of transcription factors are known to
activate gene transcription via association with a diverse
array of coactivators, some of which promote chromatin
remodeling, whereas others, such as TFIID and mediator
complexes, direct activator recruitment to the transcrip-
tional machinery (43–45). Thus, we hypothesize that the
binding of CPEB3 to a region next to the Stat5b’s activa-
tion domain likely interferes the association of Stat5b with
other coactivators to repress Stat5b-activated transcrip-
tion. Thus, identiﬁcation of which coactivator complexes
are involved in integrating Stat5b signal and convey it to
activate the basal transcription apparatus needs to be ﬁrst
investigated prior to testing our hypothesis.
Although several RNA-binding proteins, such as
Pbx-regulating protein 1 (46,47) and FUSE-binding
proteins (48), are also able to bind DNAs and function
as transcription factors, to our knowledge, nothing is
known for a translational repressor in complex with a
transcription factor to regulate gene expression. A recent
study has identiﬁed ribosomal protein S3 (RPS3), a KH
domain RNA-binding protein, was in complex with
NF-kB and enhanced NF-kB-mediated transcription
(49). Although RPS3 is a subunit of 40S ribosome and
has a role in general translation, no speciﬁc mRNA has
been identiﬁed to associate with RPS3. Despite CPEB2
and CPEB4 share identical RNA-binding speciﬁcity with
CPEB3 and constantly shuttle between nucleocytoplasmic
compartments, they have no obvious inﬂuence on the level
of EGFR once knocked down in neurons. Since CPEB2
and CPEB4 do not associate with Stat5b, it appears that
the interaction between a translation regulator and a tran-
scription factor may help CPEB3 has regulatory roles in a
spectrum of genes different from CPEB2 and CPEB4. The
nuclear import of Stat5b is not inﬂuenced by CPEB3 and
NMDA. Because the fact that Stat5b activates transcrip-
tion of EGFR gene and CPEB3 offsets its activity, it seems
illogical for CPEB3 and Stat5b to import simultaneously
to the nucleus. Moreover, CPEB3 and Stat5b interaction
is not disrupted by NMDA treatment and a nuclear form
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Figure 7. EGFR inﬂuences spatial memory. (A) To test geﬁtinib
potency, the hippocampal neurons were stimulated with EGF in the
presence or absence of geﬁtinib. The EGFR kinase activity was
indicated by p-Y1068. (B) No difference in the swimming speed in
the water maze task among vehicle, EGF and geﬁtinib-treated mice.
(C) Intervention of the kinase activity of EGFR in the brain with EGF
(activation) and geﬁtinib (inhibition) affects the learning accuracy and
latency to escape in Morris water maze tasks. The accuracy was
calculated per day as the trial number that the mice successfully
climb onto the invisible platform divided by total four trials. The
geﬁtinib group (n=10) showed slower and impaired learning in
Morris water maze when compared to the control vehicle group
(n=11) as judged by reduced learning accuracy (left plot, P=0.021)
and increased latency (right plot, P=0.016) to locate the invisible
platform for the four consecutive training days. In contrast, the
EGF-treated group (n=12) showed a trend of enhanced learning
accuracy (left plot, P=0.074) and decreased latency (right plot,
P=0.452). The P-value was calculated using the two-way ANOVA
least square difference (LSD) analysis. (D) For the probe trial when
the platform was removed after the 4-day training, the distance (left
plot) and the percentage of time (right plot) that EGF- and
geﬁtinib-treated mice swam in the target quadrant where the platform
used to be were increased and reduced, respectively, when compared to
the vehicle-infused mice. The P-value was calculated using the one-way
ANOVA LSD test to compare the statistical difference between groups.
Nucleic Acids Research, 2010,Vol.38, No. 21 7455of CPEB3, CPEB3NLS, has stronger suppression effect
on Stat5b-dependent transcription than CPEB3 in the
promoter assays, so it is expected that NMDA-induced
nuclear accumulation of the repressor CPEB3 is likely to
further downregulate Stat5b-dependent EGFR gene tran-
scription in neurons. Nonetheless, due to the long half-life
of EGFR mRNA (>4h, Figure 5B) and prolonged
NMDAR activation-induced neuronal toxicity, we can
not directly demonstrate that EGFR transcription is
downregulated by NMDA stimulation in a CPEB3-
dependent manner. It remains to be identiﬁed the
speciﬁc importins and non-canonical nuclear localization
sequences in CPEB3 responsible for its import to further
address the physiological signiﬁcance of NMDA-induced
nuclear accumulation of CPEB3.
Because pharmacological intervention of the kinase
activity of EGFR in the brain affects spatial memory,
EGFR is a PRP that modulates learning and memory.
Hence, there should be caution regarding potential cogni-
tive side-effects when using EGFR-targeted drugs to treat
brain tumors. Since EGFR signaling leads to parallel ac-
tivation of several processes, such as MAPK and PI3K-
Akt signaling pathways that have been demonstrated to
play important roles in plasticity and memory (50–53),
even a subtle change in EGFR expression likely has sig-
niﬁcant impact on plasticity. In CPEB3-deﬁcient neurons,
the EGFR level is elevated. Interestingly, EGFR expres-
sion was found upregulated in forebrain regions of schizo-
phrenics (54) and EGF administration in neonatal rats
induced various behavioral hallmarks of schizophrenia
(55). Generation of conditional CPEB3 knockout mice is
in process to address whether aberrant EGFR expression
will cause abnormal signaling and aberrant behaviors
in mice.
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